These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38283636)

  • 1. Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus.
    Albai O; Braha A; Timar B; Sima A; Deaconu L; Timar R
    Diabetes Metab Syndr Obes; 2024; 17():271-282. PubMed ID: 38283636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19.
    Infante M; Pieri M; Lupisella S; Mohamad A; Bernardini S; Della-Morte D; Fabbri A; De Stefano A; Iannetta M; Ansaldo L; Crea A; Andreoni M; Morello M
    Curr Med Res Opin; 2023 Apr; 39(4):505-516. PubMed ID: 36749566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Fachim H; Mudaliar RN; Syed A; Naseem A; Gibson JM; Bowden Davies KA; Peek N; Anderson SG; Peng Y; Ollier W
    Diabetes Ther; 2022 May; 13(5):1007-1021. PubMed ID: 35325361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes.
    Albai O; Frandes M; Sima A; Timar B; Vlad A; Timar R
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
    Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
    Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between HbA1c Levels and Mortality Rates in Hospitalized COVID-19 Patients.
    Bhagat A; Buxton L; Hasan M
    Cureus; 2022 Nov; 14(11):e31347. PubMed ID: 36514608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.
    Greco C; Pirotti T; Brigante G; Filippini T; Pacchioni C; Trenti T; Simoni M; Santi D
    Acta Diabetol; 2023 Jun; 60(6):817-825. PubMed ID: 36939895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.
    Xu AY; Wang SH; Duong TQ
    BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37295808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes associates with mortality in critically ill patients with SARS-CoV-2 pneumonia: No diabetes paradox in COVID-19.
    Bellaver P; Schneider L; Schaeffer AF; Henrique LR; Camargo JL; Gerchman F; Leitão CB; Rech TH
    Heliyon; 2023 Aug; 9(8):e18554. PubMed ID: 37576227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
    Barbosa M; Marques-Sá J; Carvalho C; Fernandes V
    Arch Endocrinol Metab; 2023 Jun; 67(6):e000649. PubMed ID: 37364151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.
    Bhatti R; Khamis AH; Khatib S; Shiraz S; Matfin G
    JMIR Public Health Surveill; 2020 Dec; 6(4):e22471. PubMed ID: 33284130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia.
    Krishnasamy S; Sheikh D; Ali T; Clemons V; Furmanek S; Mohamed Fawzy Abdelhaleem AA; Salunkhe V; Akbar UA; Chlebowy D; Ramirez J; Arnold F
    Endocr Pract; 2022 Aug; 28(8):780-786. PubMed ID: 35671878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hyperglycaemia at-admission & diabetes mellitus with 28 day mortality in patients admitted with moderate-severe SARS-CoV-2 infection: A retrospective study.
    Kurian NM; B Yadav SC; Gurjar M; Mishra P; Sanjeev OP; Azim A; Gupta D; Hashim Z; Verma A; Bhatia E; Ghatak T; Singh RK; Nath A; Sahoo SK; Dabadghao P; Gupta S
    Indian J Med Res; 2022; 155(5&6):554-564. PubMed ID: 36348602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Japanese Patients with BMI < 35 kg/m
    Seki Y; Kasama K; Yasuda K; Yokoyama R; Porciuncula JP; Kurokawa Y
    Obes Surg; 2018 Aug; 28(8):2429-2438. PubMed ID: 29502278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India.
    Raghavan A; Nanditha A; Satheesh K; Susairaj P; Vinitha R; Chandrasekaran S; Palaniappan T; Thillai Vallal S; Subair Khan A; Snehalatha C; Ramachandran A
    Diabetes Metab Syndr; 2021; 15(4):102143. PubMed ID: 34186345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.
    McDonnell ME; Garg R; Gopalakrishnan G; Mitri J; Weinstock RS; Greenfield M; Katta S; Lebastchi J; Palermo NE; Radhakrishnan R; Westcott GP; Johnson M; Simonson DC
    J Clin Endocrinol Metab; 2023 Feb; 108(3):718-725. PubMed ID: 36217580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.